Who is sponsoring NCT04844294?

NCT04844294 is sponsored by Ohio State University.

What drugs are being tested in NCT04844294?

Interventions in NCT04844294: Brief Cognitive Behavioral Therapy (BCBT), Present-Centered Therapy (PCT).

What condition does NCT04844294 study?

NCT04844294 studies Suicide, Suicidal Ideation, Suicide Attempt.

Is NCT04844294 still recruiting?

NCT04844294 is currently completed. Last updated 5 March 2025.

Last reviewed 2025-03-05 · How we verify

NCT04844294

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized Clinical Trial Testing the Effectiveness of Telemental Health for Suicidal Patients

Completed NA Last updated 5 March 2025

What this trial tests

NA trial testing Brief Cognitive Behavioral Therapy (BCBT) in Suicide in 98 participants. Completed in 30 December 2024.

Timeline

12 April 2021

Primary endpoint
30 September 2024

30 December 2024

Quick facts

Lead sponsor	Ohio State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	98
Start date	12 April 2021
Primary completion	30 September 2024
Estimated completion	30 December 2024
Sites	1 location across United States

Drugs / interventions tested

Brief Cognitive Behavioral Therapy (BCBT)
Present-Centered Therapy (PCT)

Conditions studied

Suicide — all drugs for Suicide →
Suicidal Ideation — all drugs for Suicidal Ideation →
Suicide Attempt — all drugs for Suicide Attempt →

Sponsor

Ohio State University

Who can join

18 and older, any sex, with Suicide or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The long-term goal of this study is to reduce suicidal thoughts and behaviors among treatment-seeking individuals who are experiencing suicidal thoughts or have recently made a suicide attempt. Brief cognitive behavioral therapies for suicide prevention (BCBT) has demonstrated empirical support for reducing suicide attempts as compared to treatment as usual. However, no studies to date have assessed their effectiveness when delivered via telehealth, highlighting an important knowledge gap in light of increased use of telehealth subsequent to the outbreak of the novel coronavirus (COVID-19) in the U.S. In light of this knowledge gap, the primary objective of this study will be to test the effectiveness of brief cognitive behavioral therapy (BCBT) as compared to present-centered therapy (PCT), an active comparator, for the reduction of suicide ideations and attempts when delivered via telehealth.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Telehealth Brief Cognitive Behavioral Therapy for Suicide Prevention: A Randomized Clinical Trial.
Baker JC, Starkey A, Ammendola E, Bauder CR, et al · · 2024 · cited 10× · PMID 39531231 · DOI 10.1001/jamanetworkopen.2024.45913
Changing temporal patterns in patient-reported wish to live and wish to die signal the imminent emergence and aftermath of suicide attempts: a dynamical systems analysis.
Bryan CJ, Bozzay ML, Hay J, Starkey A, et al · · 2025 · PMID 41029217 · DOI 10.1186/s12888-025-07295-0

Verify or expand the search:

Other trials of Brief Cognitive Behavioral Therapy (BCBT)

Trials testing the same drug.

NCT06094218 — Development of a Treatment Prognosis Calculator for the Prevention of Suicide · NA · recruiting

Other recruiting trials for Suicide

Currently open trials in the same condition.

NCT07404787 — Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Ho · NA · recruiting
NCT07214233 — Youth Empowerment and Safety Intervention · NA · recruiting
NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting

Other Ohio State University trials

Trials by the same sponsor.

NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog · not yet recruiting
NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients · NA · enrolling by invitation
NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment · NA · not yet recruiting
NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04844294 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ohio State University
Last refreshed: 5 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04844294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing